Protara Therapeutics

Protara Therapeutics, based in New York, the United States, is a biotechnology company. Protara is a biopharmaceutical company developing investigational therapies for oncology and rare diseases. On ClinicalTrials.gov it is the lead sponsor of 2 recruiting or active phase 2 and phase 3 interventional cancer trials (1 in phase 3), testing TARA-002 in bladder & urothelial cancer. The largest, NCT07480356 (Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer), plans to enrol 284 participants. Sponsor and trial facts are from the ClinicalTrials.gov registry, checked on 2026-09-11; company facts are from the official website.